PMC:7600245 / 31503-31788
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T117 | 44-52 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T286 | 10-11 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T287 | 29-34 | http://purl.obolibrary.org/obo/CLO_0007225 | denotes | label |
| T288 | 157-158 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | b |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T457 | 29-34 | Chemical | denotes | label | http://purl.obolibrary.org/obo/CHEBI_35209 |
| T458 | 136-145 | Chemical | denotes | ribavirin | http://purl.obolibrary.org/obo/CHEBI_63580 |
| T459 | 150-153 | Chemical | denotes | INF | http://purl.obolibrary.org/obo/CHEBI_52999 |
| T460 | 162-181 | Chemical | denotes | lopinavir/ritonavir | http://purl.obolibrary.org/obo/CHEBI_145924 |
| T461 | 162-171 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
| T462 | 172-181 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T230 | 0-285 | Sentence | denotes | Moreover, a randomized, open-label trial in COVID-19 adults (n = 127) with mild to moderate symptoms in Hong Kong suggested that adding ribavirin and INF-β-1b to lopinavir/ritonavir increased the efficacy of the treatment when it was initiated within 7 days of the symptoms onset [59]. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 894 | 154-158 | Gene | denotes | β-1b | Gene:1 |
| 908 | 136-145 | Chemical | denotes | ribavirin | MESH:D012254 |
| 909 | 162-181 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |
| 919 | 44-52 | Disease | denotes | COVID-19 | MESH:C000657245 |